What is safe and what to avoid in this patient population
No Clear Connection Between Inflammation & Disease Progression in AS
TNF blockers decrease symptoms but seem to have little impact on structural damage
Research on IL-17 Cytokine May Lead to Novel Therapies for RA
Research in the laboratory of John D. Mountz, MD, PhD, is opening up a whole new field of study in rheumatoid arthritis (RA).
Are We Playing It Safe?
Tumor necrosis factor alpha inhibition and the risk of solid malignancies
Unique Meeting Accelerates RA Research
More than 50 rheumatoid arthritis (RA) investigators from across the U.S. recently met in Ft. Worth, Texas, to share information, present data and results from their innovative RA research projects, and brainstorm ways to work more closely together to find a cure for the disease.
REF’s Campaign to Support RA Research Nears its Initial Funding Target
The REF’s campaign to support RA research nears its initial funding target
The Key to Early Rheumatoid Arthritis
The conundrum of classification versus diagnosis
How to Provide Compassionate Care When Touch Is Painful
Providing compassionate care when touch is painful
Research Offers Hope of New Therapies to Prevent Bone Loss and Destruction
A study recently published in Annals of the Rheumatic Diseases shows promise for potential new therapies to prevent bone loss and bone destruction in patients with rheumatoid arthritis (RA).
Our Commitment to Research
The ACR has a wide range of programs to support investigations in rheumatology
- « Previous Page
- 1
- …
- 65
- 66
- 67
- 68
- 69
- …
- 74
- Next Page »